Enterprises Build Owned Accelerator Clusters
Regulated industries increasingly buy dedicated frontier-scale accelerator infrastructure rather than renting cloud compute, sustaining demand for the newest Nvidia platforms and making performance-per-megawatt the deciding spec.
forming · confidence 40 · Emerging (watchlist) · tracking since July 21, 2026 · updated July 21, 2026
Why the conviction moved
- Jul 21Strengthened +5
Bristol Myers Squibb committed to deploying Nvidia DGX Vera Rubin NVL72 systems as a dedicated AI factory for drug discovery, with Nvidia claiming up to ten times more performance per megawatt — a regulated pharma buyer owning frontier accelerator infrastructure and buying on perf-per-megawatt.
Source trail
Supporting · July 21, 2026
Bristol Myers Squibb Commits to an Nvidia Vera Rubin AI Factory for Drug Discovery
Bristol Myers Squibb committed to deploying Nvidia DGX Vera Rubin NVL72 systems as a dedicated AI factory for drug discovery, with Nvidia claiming up to ten times more performance per megawatt — a regulated pharma buyer owning frontier accelerator infrastructure and buying on perf-per-megawatt.
NVIDIA Blog
Unlock full source trail, score history, and daily updates.
Unlock Trends